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Single tryptophan Y160W mutant 
of homooligomeric E. coli purine 
nucleoside phosphorylase implies 
that dimers forming the hexamer 
are functionally not equivalent
Marta Narczyk1, Łukasz Mioduszewski1,4, Aleksandra Oksiejuk1,5, 
Maria Winiewska‑Szajewska1,3, Beata Wielgus‑Kutrowska1, Adrian Gojdź2, Joanna Cieśla2 & 
Agnieszka Bzowska1*
E. coli purine nucleoside phosphorylase is a homohexamer, which structure, in the apo form, can be 
described as a trimer of dimers. Earlier studies suggested that ligand binding and kinetic properties 
are well described by two binding constants and two sets of kinetic constants. However, most of 
the crystal structures of this enzyme complexes with ligands do not hold the three‑fold symmetry, 
but only two‑fold symmetry, as one of the three dimers is different (both active sites in the open 
conformation) from the other two (one active site in the open and one in the closed conformation). Our 
recent detailed studies conducted over broad ligand concentration range suggest that protein–ligand 
complex formation in solution actually deviates from the two‑binding‑site model. To reveal the details 
of interactions present in the hexameric molecule we have engineered a single tryptophan Y160W 
mutant, responding with substantial intrinsic fluorescence change upon ligand binding. By observing 
various physical properties of the protein and its various complexes with substrate and substrate 
analogues we have shown that indeed three‑binding‑site model is necessary to properly describe 
binding of ligands by both the wild type enzyme and the Y160W mutant. Thus we have pointed out 
that a symmetrical dimer with both active sites in the open conformation is not forced to adopt this 
conformation by interactions in the crystal, but most probably the dimers forming the hexamer in 
solution are not equivalent as well. This, in turn, implies that an allosteric cooperation occurs not only 
within a dimer, but also among all three dimers forming a hexameric molecule.
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Km  Michaelis constant
Vmax  Maximal velocity
Purine nucleoside phosphorylases (PNP, E.C. 2.4.2.1.) are ubiquitous enzymes of the purine salvage pathway 
enabling the cell to recover purine bases and ribose-1-phosphate from used purine  nucleotides1. PNPs catalyse 
the following reaction: β-purine nucleoside + orthophosphate ↔ purine base + α-D-pentose-1-phosphate. Tri-
meric sub-family contains PNPs specific vs. 6-oxopurine nucleosides, and such enzymes are found in mammals 
and in some microorganisms, while hexameric PNPs present mainly in prokaryotes are less specific and accept 
many substituents at position 6 of the purine  ring1. Both subfamilies are potential targets for antitumour, immu-
nosuppressive, and/or antiparasitic  agents1–3. Differences in specificity between trimeric mammalian PNPs and 
hexameric, less specific PNPs offer a basis for enzyme-activating prodrug gene therapy by empowering selective 
killing of tumour cells expressing the E. coli PNP  gene4–7. These potential medical applications of PNPs encour-
age researchers to study their molecular mechanism and to search for their potent, selective and membrane 
permeable inhibitors.
Nevertheless, PNPs are also remarkable molecular machines and many molecular features that make them 
such efficient catalysts are still unclear. The biologically active form of the E. coli enzyme is a homohexamer, 
consisting of six monomers with an identical aminoacid sequence and, in the apo form, exhibiting also identi-
cal three-dimensional structure. However, the whole hexameric molecule has a three-fold symmetry, and can 
be described as a trimer of dimers. Moreover, each of the dimers has a two-fold symmetry, with the symmetry 
axis perpendicular to three-fold symmetry axis, so the apo enzyme may be regarded as a dimer of trimers 
as well (Fig. 1, left panel)8. Dimers, but not monomers, seem to have all the necessary features to conduct 
catalysis, because monomers within a dimer mutually donate two amino acids to complete the active site of 
the  neighbour9,10. The earlier models describing enzyme kinetics and ligand binding have included two sets of 
kinetic and two binding constants, respectively, reflecting allosteric cooperation between subunits in a  dimer9,11,12. 
Therefore, the hexameric (not simply dimeric) form adopted by this enzyme seems to be necessary solely in order 
to ensure stability of the enzyme molecule. This reason for homooligomerisation is observed for many other 
 enzymes14 and we have already shown that it is important for this particular enzyme as  well15.
However, most of the crystal structures of binary (with phosphate) and ternary (with phosphate and various 
nucleosides or purine bases) complexes of this enzyme available so far do not hold this three-fold  symmetry13,16–19. 
Binding of a phosphate substrate, induces the conformational change leading to the closure of the active site 
pocket (Fig. 1, right panel). But this occurs only in some subunits. Two of the dimers are unsymmetrical, with 
one active site in the open and the other in the closed active site conformation (“open-closed” dimer), whereas 
the third dimer has both active sites in the open conformation (Fig. 1, middle panel). Since the closure of the 
active site is essential for  catalysis9,13, only two “open-closed” dimers seem to be active.
Our earlier X-ray  studies13,19 suggest that the open sites of the “open-open” dimer differ from the open sites 
of the “open-closed” dimer. In this study, we present the results of our research addressing the question whether 
the “open-open” dimer is forced to be symmetric by some interactions present only in the crystalline form, or 
it also differs from its neighbours in solution. In the latter case, its presence should be taken into account in the 
study of the molecular mechanism of catalysis. Therefore, we have examined in detail the properties in solu-
tion of the binary complex of E. coli PNP with phosphate, and of the ternary complex with phosphate and the 
nucleoside, formycin A, the structural analogue of the substrate, adenosine, and the potent inhibitor (formycin 
A, see Fig. 2, inset).
Analysis of the fluorescence titration data for complex formation of PNP with phosphate was the first indica-
tion that two types of dimers observed in the crystallographic structures were not just a crystallographic artefact. 
As the wild type PNP exhibits uniform changes of fluorescence upon phosphate binding, all titration curves, 
irrespectively of excitation and observation wavelength, have the same shape and are not visibly multiphase, two 
approaches were employed to further investigate the observed phenomena. First, a single-tryptophan Y160W 
mutant was engineered, with the mutation in a close proximity to the active site, but without significant inter-
actions with ligands (Fig. 2). Since each subunit of the wild type PNP contains six tyrosine residues and no 
 tryptophan1, this approach resulted in a protein with a significantly enhanced fluorescence response to ligand 
binding, and with retained catalytic and kinetic properties of the WT enzyme. Second, several experimental 
techniques were used to study the formation of binary and ternary complexes in order to explore the physical 
properties of the enzyme other than the intrinsic fluorescence of the protein.
Results
Y160W mutant shares typical features with the WT E. coli PNP. Analytical centrifugation con-
firmed that Y160W mutation did not affect the oligomeric state of the protein in solution. Virtually all protein 
molecules form a single band profile (Figure S1) with a sedimentation coefficient  s20,w = 7.80 which corresponds 
to the molecular weight of 150 kDa, in agreement with the hexameric assembly (6 × 25.970 = 155.8 kDa).
Crystallographic structure of the ternary complex of the Y160W mutant with two inhibitors, substrate ana-
logues, sulfate ion and formycin A (PDB 6XZ2) shows that mutation has no significant influence on the secondary 
and ternary structure of the protein as well. Also, interactions of formycin and sulfate in the active site of the 
enzyme are comparable to those observed for the WT enzyme (Fig. 2). Complex crystallised in P  6122 space group 
with the half of the hexamer in the asymmetric unit. All active sites are in the open conformation, consistent 
with the data on protein crystallisation in the absence of phosphate  conditions13. Both ligands are in the same 
positions as in the active site of the WT PNP (PDB 4TS3,  4TS919). Sulfate ion is bound in the hydrogen bond 
distance from Arg87, Arg43* (from the neighbouring subunit), Ser90, Gly20. The side of chain Arg24 points 
away from the active site, what is typical for the open conformation of the active  site9,13. Ribose of formycin A 
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Figure 1.  Left panel: Schematic view of the E. coli PNP in the apo form (PDB  1ECP8). All dimers are 
symmetrical, as all subunits have the same, elongated structure of the helix H8, resulting in the open 
conformation of the active site. The overall structure of the enzyme may be therefore regarded as a trimer of 
dimers as well as a dimer of trimers since the molecule has 32 point group symmetry. Middle panel: Schematic 
view of the E. coli PNP complexed with phosphate (PDB  4TS319). In two subunits (here shown in cyan) binding 
of phosphate leads to the segmentation of the H8 helix and the partial closing of the active site pocket. Two 
dimers become unsymmetrical (shown here with cyan and green subunits), as they differ in the conformation of 
the N-terminal part of the H8 helix (shown in red). The third dimer (with green subunits) has both active sites 
in the open conformation, hence is symmetrical. The overall structure of the enzyme in this case is therefore 
a dimer of trimers. This kind of architecture is observed in the most of the crystal structures of E. coli PNP 
complexes available up to now, binary (with phosphate) and ternary (with phosphate and various nucleosides 
or purine bases). Right panel: Subunits in the open and closed conformation of the active site from the structure 
depicted in the middle panel, were overlaid to show differences in these two active site conformations: the 
segmentation of the helix H8 and the movement of its N-terminal part (shown in darker shades of green and 
cyan, respectively) and the loop towards the active site pocket (indicated by the red arrow).
Figure 2.  Comparison of active sites of the Y160W mutant (PDB 6XZ2, violet) and the WT PNP (PDB  4TS319, 
green) complexed with formycin A and sulfate. Aminoacids forming the active site and the network of hydrogen 
bonds are shown. The residues His4 and Arg43 belonging to the neighbouring subunit in a dimer are marked 
with *. Inset: Formycin A, a structural analogue of adenosine, the natural E. coli PNP substrate. Due to the C–C 
glycosidic bond, that links the base and the pentose, formycin A is not a substrate for PNP, but an inhibitor, 
competitive vs. the nucleoside substrate. Note the difference in the base ring numbering when compared with 
the purine ring numbering.
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is involved in hydrogen bonds with sulfate ion, Glu181 and His4* (from the neighbouring subunit), whereas 
aglycon—with Asp204 and Ser90.
The effect of the Y160W mutation on catalytic properties of the enzyme was checked by measuring the 
specific activity of the mutant vs. typical PNP substrates (Table 1), by collecting full kinetic data for guanosine, 
7-methylguanosine and phosphate as variable substrates (Table 2), and by measuring the effect on the catalysis 
of the typical inhibitor, formycin A, competitive vs. nucleoside. Activity of the WT PNP and the mutant towards 
natural and modified substrates is very similar, but kinetic constants tend to be slightly higher for the mutant 
than those observed for the WT enzyme. However, all reaction models are retained: Michaelis–Menten for the 
nucleoside substrate, two allosterically interacting active sites for phosphate as a variable substrate, and competi-
tive inhibition of formycin A vs. nucleoside substrate. All these results justify the use of the Y160W mutant to 
study formation of E. coli PNP complexes with ligands.
Effects of enzyme‑phosphate interaction on enzyme fluorescence. For the WT protein, as it 
has no tryptophan in the structure, increasing concentration of phosphate (Pi) in solution leads to only small 
quenching of the fluorescence without any significant changes in the shape of the protein fluorescence spectra, 
regardless of the excitation wavelength (Fig. 3). However, for the Y160W mutant changes in the protein fluores-
cence upon phosphate binding are much more diverse. Fluorescence spectra were collected with excitation at 
the maximum of the tyrosine (274 nm) and tryptophan (278 nm) absorption spectra, and at 290 nm where only 
tryptophan absorbs. Increasing the concentration of phosphate in the solution quenches or enhances the intrin-
sic fluorescence of the Y160W mutant (Fig. 3), and the effects strongly depend on the excitation wavelength and 
the region of the fluorescence spectrum. There are no isosbestic points, indicating the presence of more than 
two species (Fig. 3).
Table 1.  Enzymatic specific activity of the Y160W PNP mutant vs. natural substrates (inosine, adenosine 
and guanosine) and vs. 7-methylguanosine compared with the similar data for the WT E. coli PNP. Data were 
obtained at pH 7.0, in 50 mM Hepes buffer, 25 °C, with 50 mM phosphate using spectrophotometric methods 
described in “Methods” section. *From13.
Substrate
Mutant
Ino Ado Guo m7Guo
[U/mg] [%] [U/mg] [%] [U/mg] [%] [U/mg] [%]
WT* 103.2 ± 4.0 100 58.5 ± 5.9 100 60.4 ± 6.7 100 21.4 ± 1.6 100
Y160W 91.1 ± 8.9 88 65.6 ± 14.2 112 36.2 ± 2.0 60 23.2 ± 1.2 108
Table 2.  The summary of kinetic properties of the WT PNP and the Y160W mutant vs. natural substrates and 
vs. 7-methylguanosine. Data were obtained at pH 7.0, in 50 mM Hepes buffer, at 25 °C, with 50 mM phosphate 
using spectrophotometric methods described in “Methods” section. Parameters were obtained from the global 
fitting and are shown together with their standard deviations. *From 19,  250 μM  m7Guo.
Kinetic parameter WT Y160W
Model Allostery Eq. (2) Allostery Eq. (2)
Phosphate as variable substrate, 0.4 mM  m7Guo
Km [μM] 15 ± 4* 18.7 ± 2.7
Vmax [U/mg] 10.8 ± 0.7* 11.7 ± 0.4
a 267 ± 232* 390 ± 122
b 0.76 ± 0.06* 0.94 ± 0.05
Kinetic parameter WT Y160W
Model Michaelis–Menten Eq. (1) Michaelis–Menten Eq. (1)
Guo as variable substrate, 50 mM phosphate
Km [μM] 28 ± 4 128 ± 2
Vmax [U/mg] 51.1 ± 2.3 42.8 ± 0.3
Kinetic parameter WT Y160W
Model Michaelis–Menten Eq. (1) Michaelis–Menten Eq. (1)
m7Guo as variable substrate, 50 mM phosphate
Km [μM] 27.2* 71.3 ± 3
Vmax [U/mg] 22.7 ± 0.3 21 ± 1
Kinetic parameter WT Y160W
Model Competitive inhibition Eq. (3) Competitive inhibition Eq. (3)
Formycin A  (m7Guo as variable substrate, 50 mM phosphate)
Ki [μM] 5.3 ± 0.4 42 ± 4
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Based on the analysis of the differential spectra obtained for the Y160W mutant (Fig. 3) eight combinations 
of excitation and observation wavelengths were selected for titration measurements, in order to obtain curves 
with the greatest possible total change in fluorescence, and as many various titration curve shapes as possible. 
The typical series of titrations for both WT protein and Y160W mutant are shown in Figure 4. Even visual 
analysis of the curves obtained for the mutant suggests that binding is at least a three-step process, as some of 
the curves have more than one extremum (in the case of 290 nm/360 nm and 274 nm/365 nm excitation/obser-
vation wavelength, respectively). Curves were analysed globally as described in “Methods” section. Details of 
a discrimination analysis of the tested models are depicted in Table S1 in the Supplementary Information. For 
both WT protein and Y160W mutant three-binding-site model describes the data best, and values of dissociation 
constants obtained are shown in Table 3. As with kinetic parameters (Tables 1 and 2), constants for the Y160W 
mutant are slightly higher than for the WT protein, although within the 3σ test,  Kd1 and  Kd3 constants for both 
proteins are consistent, only the difference between constants  Kd2 exceeds the condition of compliance of this test. 
This may mean that introducing of tryptophan at position 160 has a not negligible effect on the ligand binding 
process described by the  Kd2 constant. Most importantly, however, the model describing the complex formation 
process for both proteins is the same, i.e. three binding sites with different affinity for the ligand are observed.
Binding of phosphate from MST and CD titrations. To confirm that there are three different types of 
binding sites, a series of thermophoretic (MST), calorimetric (ITC) and circular dichroism (CD) experiments 
were performed. The shapes of the binding curves obtained from MST titrations (Fig.  5 and Figure  S2) are 
similar for WT PNP and Y160W mutant. Two-binding-site model fits the best to experimental binding curves 
(see details of the discrimination analysis, Table S1 in the Supplementary Information). The obtained values of 
the dissociation constants are shown in Table 3. Comparing these values with those obtained by fluorescence 
titrations, shows that dissociation constants determined by MST reproduce the strongest  (Kd1) and the weakest 
 (Kd3) constants obtained from fluorescence titrations analysis.  Kd2 constant is either undetectable by MST or is 
an artefact observed in fluorescence titrations.
To address this problem, calorimetric titrations (ITC) were employed, but due to the poor quality and low 
repeatability of results obtained, we decided to change the approach and perform CD titration instead. The 
near-UV CD spectra (230–300 nm) were collected to follow phosphate binding to the WT PNP and the Y160W 
mutant (Fig. 5 and Figure S4). The differential spectra of protein-phosphate complex vs. protein have the same 
shape for the WT protein and Y160W mutant, however introducing Trp at position 160 markedly changes the 
protein CD spectra, and the overall signal change is larger for the Y160W mutant (Figure S3). Titration curves 
were obtained by cross-secting the spectra in the wavelengths where the largest changes of the signal occur (see 
“Methods” section). The titration curves for both protein variants are best described by the three-binding-site 
Figure 3.  Differential fluorescence spectra of the E. coli PNP complexes with phosphate, left upper panel for 
the WT PNP (red), remaining graphs for the Y160W mutant (green), obtained at 25 °C, in 50 mM Tris/HCl 
buffer pH 7.6. The excitation wavelengths at which the spectra were measured are denoted on each graph. 
Phosphate concentrations were as follows: 10 μM, 100 μM, 1000 μM, 10 000 μM. The increase in phosphate 
concentration is marked with the gradient of the colour, black for the lowest, red (for the WT) or green (for the 
Y160W mutant) for the highest phosphate concentration. In the graphs for the Y160W mutant, the wavelengths 
chosen for the observation for each excitation wavelengths are marked by arrows. These data, together with 
the excitation wavelength shown on the graph, define conditions, in which titrations presented on Fig. 4, were 
performed. Direction of the arrows indicates only the direction of the phosphate concentration growth.
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model (see “Methods” section, Table S1 in the Supplementary Information for the details of a discrimination 
analysis). The values of dissociation constants derived from fitting this model are shown in Table 3.
Interactions of E. coli PNP with phosphate. The results of titrations performed with the three 
techniques described above, i.e., fluorescence, thermophoresis and circular dichroism, show great similarity 
(Table 3). The values of the smallest dissociation constant (describing the strongest binding) determined by all 
methods are consistent with each other in the 3σ test. The same is true for the weakest constants. The third con-
stant of 80–200 μM is unequivocally revealed by two methods, fluorescence and CD titrations. This suggests that 
in MST experiments this constant is simply undetectable. Possible reasons will be addressed in “Discussion” sec-
tion. The results presented above indicate that the interaction of E. coli PNP with phosphate in solution requires 
three binding constants for the correct description, which is consistent with the crystallographic structure of the 
enzyme with phosphate (PDB  3OOH13). In this structure, the three-fold symmetry observed for the apo enzyme 
is broken, the active site pocket is closed in only two subunits, and as a result of this conformational change, the 
three dimers that build up the enzyme are no longer structurally equivalent.
Binding of nucleoside analogue—ITC and MST titration studies. Binding studies of nucleoside 
by the WT PNP and the Y160W mutant were performed using the inhibitor, formycin A (FA, see Fig. 2, inset), 
a structural analogue of adenosine. Formycin A and formycin B, the analogues of the natural PNP substrates, 
adenosine and inosine, respectively, show strong absorption, and their fluorescence spectra overlap with that of 
the protein. Thus, fluorimetric studies employing natural emission of the protein and/or of the ligand, even at 
moderate ligand concentration, are impossible. Surprisingly, no changes in the CD signal were observed upon 
formycin A binding by either the WT or Y160W enzyme forms. Therefore,  MST experiments and additionally 
isothermal calorimetric titrations were performed to characterize the binding of formycin A by PNP.
Calorimetric titrations were performed in series for the WT protein and for the Y160W mutant, and the 
enzyme concentration range used was 70–1300 μM (Fig. 5 and Figure S5). Global analysis of each titration 
series, for both proteins, were carried out in the Sedphat  program20,21. Discrimination analysis (see “Methods” 
section and Table S1) in both cases pointed to the model with three binding sites as best describing titration 
data, and the values of dissociation constants derived from fitting of this equation are given in Table 3. In the 
case of the WT protein the errors of fitted parameters are relatively high, thus the values should be treated 
as estimates. In the case of thermophoretic measurements, even under the best conditions, the overall signal 
changes upon binding of formycin A molecules to the WT protein are relatively small, hence the analysis was 
not straightforward. The titration curves (Fig. 6) for both protein variants are clearly multiphase, indicating that 
the one-binding-site model is not consistent with the data. In the case of the WT protein, analysis of residual 
Figure 4.  Fluorescence titration curves of the enzyme with phosphate: WT (left panel) and Y160W mutant (right 
panel). Data (points), global best fit model (lines) and residual plots are presented. Titrations were performed at 25 °C, 
in 50 mM Tris/HCl buffer pH 7.6 and in following excitation/observation wavelengths for the WT enzyme: 270/310 
nm (brown), 278/312 nm (orange), 277/312 nm (green), 270/315 nm (violet), 270/320 nm (red), 270/325 nm (grey), 
278/325 (blue); and for the Y160W mutant: 278/346 nm (brown), 290/360 nm (orange), 274/365 nm (green), 274/382 
nm (violet), 278/334 nm (red), 278/339 nm (grey), 278/363 nm (blue), 290/374 (black).
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Table 3.  Dissociation constants of the WT PNP and the Y160W mutant complexes with phosphate (Pi), 
and the WT PNP/Pi and the Y160W mutant/Pi complexes with formycin A (FA), determined by various 
experimental methods. Experiments were conducted at 25 °C, in 50 mM Tris/HCl buffer at pH 7.6, and in the 
case of titrations with formycin A in the presence of 50 mM phosphate buffer pH 7.6. Dissociation constants 
obtained from the global fitting (see “Methods” section) with standard deviations are shown, and also the 
confidence intervals at 3σ level  (in parenthesis) . *In this case the confidence interval is not closed from the 
bottom, as the lower bound is lower than the lowest ligand concentration used in titrations (0.007 μM). # The 
strong absorption of FA makes fluorimetric titrations impossible even at moderate ligand concentrations.
Enzyme Titrant
Fluorescence titrations Thermophoretic titrations CD titrations
Kd ± SD
Confidence 
intervals Kd ± SD
Confidence 




Kd1 (4.4 ± 1.1) μM (1.8–6.6 ) μM (7.0 ± 3.4) μM (2.9–12.9) μM




Kd2 (84 ± 12) μM (59–118) μM (107 ± 30) μM (76–144) μM
Kd3
(1.77 ± 0.14) 
mM (1.47–2.23) mM (1.64 ± 0.14) mM (1.38–1.94) mM
(1.03 ± 0.29) 
mM (0.76–1.46) mM
Y160W Pi
Kd1 (7.0 ± 1.4) μM (4.8–10.9) μM (3.20 ± 3.06) μM (0.4–15.4) μM
(4.13 ± 3.77) 
μM (0.3–9.7) μM
Kd2 (200 ± 30) μM (179–409) μM (128 ± 28) μM (92–177) μM
Kd3 (3.2 ± 0.6) mM (2.6–5.2) mM
(1.282 ± 0.079) 
mM (1.12–1.45) mM
(2.33 ± 0.17) 
mM (2.05–2.74) mM
Enzyme Titrant
Fluorescence titrations Thermophoretic titrations Calorimetric titrations
Kd ± SD
Confidence 
interval Kd ± SD
Confidence 





(0.0107 ± 0.0074) 
μM
(0.0005–0.0334) 
μM (8.9 ± 1.9) μM (5.5–10.8) μM
Kd2 # # (55 ± 19) μM (40–81) μM
Kd3 # # (186 ± 38) μM (117–303) μM (812 ± 631) μM (321–1615) μM
Y160W/  Pi FA
Kd1 # #




(6.75 ± 0.30) 
μM (4.01–10.10) μM
Kd2 # # (110 ± 23) μM (29–246) μM
(148.9 ± 9.8) 
μM (97.0–216.3) μM
Kd3 # # (1754 ± 774) μM (994–5324) μM (655 ± 37) μM (412–1033) μM
Figure 5.  Thermophoretic titration curves of the enzyme with phosphate (left panel), CD titration curves of 
the enzyme with phosphate (middle panel), calorimetric titration curves of enzyme-phosphate complex with 
formycin A (right panel). On each panel data for the WT enzyme (violet) and the Y160W mutant (green) are 
presented: data (points), global best fit model (lines) and residual plots below. For the sake of clarity the number 
of data has been limited to one curve from each titration series. Complete data are shown in the Supplementary 
Information. Titrations were performed at 25 °C, in 50 mM Tris/HCl buffer pH 7.6. For each method and each 
protein variant the curve with the largest change of the measured physical property was chosen.
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plots of the two-binding-site model suggests a more complex model (probability from Wald-Wolfowitz run  test22 
is 0.13, number of runs is below expected value). However, fitting the three-site-model returns the  Kd1 ~  10–8 
μM, while  Kd2 and  Kd3 are similar to those obtained from the two-binding-site model. The probability from the 
Wald-Wolfowitz run test is also very low (0.002) and the number of runs exceeds the expected value. The Akaike 
 criterion23 indicates the two-binding-site model as the best (with Akaike weight equals 0.904). Thus, the two-
binding-site model was chosen as best describing data for the WT protein. The values of dissociation constants 
are shown in Table 3. The analysis in the case of the Y160W mutant was unambiguous since the overall change in 
thermophoretic signal was significant (Fig. 6). All criteria point to the three-binding-site model as best describ-
ing the data obtained. The values of dissociation constants obtained by fitting this model are shown in Table 3.
Our recently published crystal structures of the WT PNP ternary complexes with phosphate and formycin A 
(PDB ID 4TS9,  4TS319) show steps in nucleoside binding to the subunits of the enzyme hexamer. Crystallisation 
of the WT PNP complex with phosphate (at saturating concentration) and increasing concentration of formycin 
A (structure 4TS3) allowed to establish that in the first step, this inhibitor binds only in two closed active sites, 
which are located in adjacent subunits, but not belonging to the same dimer (as shown in Fig. 1, middle panel 
for the binary complex enzyme-phosphate). The position of formycin A in the active site of the Y160W mutant, 
in the structure presented in this study is virtually the same as in the active site of the WT protein (Fig. 2). In 
addition, the nucleoside is bound in only two active sites of the hexamer, in adjacent subunits but not belonging 
to the same dimer, exactly as in the partially occupied by formycin WT PNP structure 4TS3. Moreover, even in 
these active sites the ligand is not bound in all protein molecules, since the occupancy of the formycin A molecule 
was found to be 0.71. In the remaining active sites, faint electron density blobs are visible in the place usually 
occupied by a formycin molecule, suggesting that in a small percentage of the Y160W protein molecules the 
nucleoside may be bound in all active sites, as in the 4TS9 structure of the WT enzyme.
Discussion
Early studies of hexameric E. coli PNP interactions with ligands, carried out over relatively narrow ligand con-
centration range, indicated that the kinetic and binding properties of this enzyme are well described by the set 
of two kinetic constants, and two binding constants,  respectively11,12. The first crystal structure of the enzyme/
ligand ternary  complex16 revealed the presence of two conformations of the active sites, open and closed, in line 
with the results obtained for ligand binding and catalysis. However, in this structure only half of the hexamer 
was present in the asymmetric unit, hence the detailed analysis of the symmetry of the entire hexamer was not 
possible. The next published crystal  structure9 of the E. coli PNP ternary complex, which has a full hexamer 
in the asymmetric unit, showed three similar dimers, each with one closed and one open active site. Thus, the 
architecture of the whole enzyme turned out to be a trimer of dimers, which  seemed to be  consistent with 
results obtained in  solution11,12.
However, further crystallographic studies revealed that the latter  structure9 was the only one with such sym-
metry, namely with all three dimers in the “open-closed” conformation. Subsequent X-ray structures of the WT 
Figure 6.  Thermophoretic titration curves of PNP-Pi complexes with formycin A: WT (left panel) and Y160W 
(right panel). Data (points), global best fit model (lines) and residual plots are presented. Titrations were 
performed at 25 °C, in 50 mM Tris/HCl buffer pH 7.6 and with the relative heating laser power at 80% for both 
WT protein and Y160W mutant. Seven repetitions of each titration were measured.
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E. coli PNP complexed with various ligands, when one of the ligands is  phosphate13,17–19, do not show a trimer 
of dimers architecture, with the three-fold symmetry axis, but rather a dimer of trimers, having two-fold sym-
metry, as only two of the dimers are in “open-closed” conformation. In the third dimer both active sites remain 
open, breaking the three-fold symmetry. However, slight differences in the structure of open sites forming the 
“open-closed” dimers and open sites in the “open-open”  dimer13,19 suggested, that there are three types of active 
sites, not just two. This discrepancy between the structural studies and the results obtained in solution was a 
rationale for undertaking experiments presented in this report.
Interaction of E. coli PNP with phosphate, investigated by fluorescence titrations over a broad range of ligand 
concentration yielded binding curves that are best described by a model with three dissociation constants, 
consistent with the symmetry of the enzyme molecule observed in the crystal. The engineering of a single tryp-
tophan Y160W mutant, binding studies exploring also physical properties other than the intrinsic fluorescence 
of the protein and its complexes, as well as crystallisation of the mutant in a complex with substrates analogues 
were used to further investigate whether this type of symmetry actually exists when the protein is in solution.
Binding of phosphate was followed by fluorescence, circular dichroism and thermophoretic titrations. In 
the case of two former methods, for both WT PNP and Y160W mutant titration curves are best described by a 
model of three binding sites, while a thermophoretic titrations are best described by just two-binding-site model 
(Table 3). Comparing the values of the dissociation constants shows that the constants describing the strongest 
binding obtained by all three selected techniques, are consistent with each other (under the 3σ test). The same is 
true for the largest dissociation constant, describing the weakest binding. Two conformations of active sites, open 
and closed, with elongated and segmented helix H8, respectively, are visible in the crystallographic structures 
(Fig. 2), and at the same time opposite changes in the thermophoretic mobility are observed upon binding of 
phosphate to sites in the closed and in the open conformations, as depicted on Fig. 5, left panel and on Figure S2. 
Thus, the thermophoretic signal for the middle constant may simply be hidden between these two signals of 
opposite sign, which may account for the fact that the “middle” constant,  Kd2, is not detected by the MST. How-
ever, there is also another explanation. MST is a technique that relays on changes in protein structure, significant 
enough to influence the shape and hydration shell of the molecule, and thus the thermophoretic mobility. It is 
possible that the processes occurring in the protein molecule due to binding described by this constant just do 
not significantly affect these parameters. Fortunately, phosphate binding is associated with the significant arrest 
of the molecular motion, observed in the protein backbone fragments that are flexible in the ligand-free state, 
what was detected in the proton/deuter exchange  experiments24. Such changes in the protein chain mobility are 
reflected in the intrinsic protein fluorescence and in the aromatic amino acids surrounding phosphate, giving 
rise to the CD signal for all three types of binding sites.
The next thing was to analyze binding of the nucleoside substrate. Calorimetric studies of binding by both WT 
protein and the Y160W mutant showed that three-binding-site model fits to the experimental titration curves 
the best. In the case of thermophoretic titrations, the two-binding-site model and the three-binding-site model 
better describe the data for the WT PNP and Y160W mutant, respectively. This difference for the two enzyme 
variants should rather be attributed to the better quality of titration curves obtained for the mutant, rather than 
to the actual difference in the binding model, since the total change in thermophoresis signal upon ligand binding 
is much larger and therefore the signal to noise ratio is better yielding the more “featured” curves (Fig. 6). Hence, 
three-binding-site model describing complex formation with the nucleoside seems valid for both protein variants.
The structure of the ternary complex of the Y160W mutant with sulfate and formycin A described in this 
study has a nucleoside bound only in two active sites per hexamer, located in the neighbouring subunits, but 
not belonging to the same dimer. Since phosphate was not present during the crystallisation, all active sites are 
in the open conformation. However, the distribution of occupied active sites makes this structure resemble the 
structure of the WT enzyme obtained at not saturating concentration of formycin A, captured as the first step in 
binding of this ligand by  crystallographic “snapshots”. In the latter structure there is an analogous distribution 
of the occupied (and closed) active  sites19. The distribution of the nucleoside molecules in the Y160W enzyme 
subunits indicates that although all active sites are in the same open conformation, they do not share the same 
affinity to the ligand and are therefore not equivalent. Three binding constants necessary to describe the ther-
mophoretic titration curves and similarity of the curve describing the change in thermophoretic signal for both 
protein variants indicate that in the saturating phosphate concentration in crystallographic structures of the 
Y160W mutant, some active site pockets will most probably be closed, similarly as in the case of the WT enzyme.
The Y160W mutant turned out to be an excellent tool supporting the investigation of the interactions of 
hexameric E. coli PNP with ligands. The mutant not only yielded the expected more informative intrinsic pro-
tein fluorescence curves but also, unexpectedly, the calorimetric and thermophoretic titrations curves with a 
greater overall change in the measured parameter. The better signal-to-noise ratio and better reproducibility 
resulted in higher reliability of the obtained data. Using this tool, we have shown that breaking the three-fold 
symmetry, which is characteristic of most of the crystal structures of the hexameric E. coli PNP complexes with 
various ligands, is not a crystallographic artefact. Consistent with the two-fold rather than the three-fold sym-
metry of the overall enzyme architecture, this study indicates that the active sites in the open conformation of 
the “open-open” dimer most likely differ from the sites in the open conformation of the “open-closed” dimer, 
because three binding constants, not just two, are necessary to properly describe the interaction of E. coli PNP 
with both its substrates, the phosphate and the nucleoside (Fig. 7). Thus, also in solution, the three dimers mak-
ing up the hexameric architecture of this enzyme are most likely not functionally equivalent. Two of them, with 
open and closed conformations of active sites, are catalytically active, while the third, “open-open” dimer is able 
to bind ligands but cannot undergo conformational change, consisting in closing of one active site, which is a 
necessary step in catalysis.
In this context it is worth mentioning once again that there is only one structure of the ternary complex of E. 
coli PNP with its ligands, in which the three-fold symmetry is maintained, and all three dimers occur with one 
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monomer in the open and one in the closed conformation of the active  sites9. The results described here, together 
with the presence of the aforementioned  structure9, as well as our previous studies showing that dimers tend to 
form a hexamer because they are not stable as single  molecules15, indicate that the molecular mechanism of E. 
coli PNP catalysis should take into account not only the cooperation between the two dimer-forming subunits, 
as indicated by the kinetic properties of this  enzyme11 and initial ligand binding  studies9,12,13, but also a cross-
talk of all six hexamer subunits. The question thus arises whether under optimal conditions this cross-talk can 
lead to the “open-closed” conformation of all three dimers hence to a fully active enzyme, or the third dimer is 
doomed to be in the catalytically inactive “open-open” conformation. We tackle this problem in detail in our 
next study on this fascinating enzyme.
Methods
Chemicals. Formycin A was from Berry & Associates, Inc. (USA), adenosine, inosine, guanosine and 
xanthine oxidase from bovine milk (1 U/mg) were obtained from Sigma-Aldrich (USA). 7-methylguanosine 
 (m7Guo) was synthesised from guanosine according to Jones’ and Robins’ method involving methyl  iodide25. 
This yields the preparation free from sulfate, which as an ion resembling phosphate could bias the results. All 
other chemicals were from Roth (Germany) or Sigma-Aldrich (USA), and were of the highest available purity. 
Background contaminant phosphate in buffers and other chemicals used in this study was measured spectro-
photometrically using the method involving phosphomolybdate complex reduced by ascorbic  acid26.
PNP Y160W mutant. The E. coli strain with the pSE380 plasmid carrying E. coli PNP DeoD gene was a 
kind gift from Dr. Joanne L. Turnbull. The plasmid was a template in a site-directed mutagenesis performed 
with the use of Invitrogen GeneTailor Site-Directed Mutagenesis System (Invitrogen, USA) according to manu-
facturer protocol. Forward primer used for introducing the Y160W point mutation was as follows (the altered 
codon is underlined): 5′-TCT CCG CTG ACC TGTTC TGG TCT CCG GACG-3′. The reverse primer was 5′-AGA 
ACA GGT CAG CGG AGA ACA GGT TAC CCA CC-3′. The synthesis of oligonucleotide primers and the sequenc-
ing of the mutated PNP gene were done by Genomed S.A. (Poland).
The E. coli DH5α-T1 cells containing the recombinant pSE380/PNPY160W plasmid were grown in Super-
broth medium (2% peptone, 0.2% sodium phosphate (dibasic), 0.1% potassium phosphate (monobasic), 0.8% 
sodium chloride, 1.5% yeast extract, 0.2% glucose and 50 μg/ml ampicillin) at 37 °C with constant shaking (250 
rpm) to  OD600 = 0.42 and the culture was induced with 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG). 
The cells were grown for additional 5 h in the same conditions and harvested by centrifugation for 20 min at 
4000×g at 4 °C.
Figure 7.  The schematic view of the E. coli PNP hexameric molecule, in the apo form, with the three-fold and 
the two-fold symmetry axes (left, based on PDB  1ECP8), and in the complexes with ligands, phosphate and 
nucleoside (right). In just one ternary complex of the E. coli PNP with its ligands (PDB 1K9S)9 the three-fold 
symmetry is retained (upper right), and all three dimers are with one monomer in the open (blue) and one in 
the closed (green) conformation of the active sites. The binary enzyme-phosphate complex, and the majority of 
various ternary enzyme-phosphate-nucleoside complexes show only two-fold symmetry (lower right, see also 
Fig. 1), as one of three dimers is symmetric (rotten green), hence different than two other unsymmetrical dimers 
(blue-green). The present study shows that this is more likely not a crystallographic artefact as also in solution 
the three-binding-site model is necessary to properly describe interaction of this enzyme with ligands, hence 
dimers are probably also functionally not equivalent.
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The purification procedure was based on the previously published  method27, but the additional chroma-
tography step was added. The cell pellet obtained from 2.5 l of the bacterial culture was re-suspended in 50 ml 
of homogenizing buffer H (100 mM Tris–HCl, pH 7.6, 2 mM EDTA, 10% glycerol (v/v), 1 mM DTT, 50 mM 
NaCl, 0.4 mg/ml lysozyme and 0.015 mg/ml PMSF), incubated on ice for 30 min, sonicated and centrifuged 
for 20 min at 43,000×g at 4 °C. The supernatant was filtered through 4 layers of gauze, supplemented with an 
equal volume of 100 mM Tris–HCl buffer (pH 7.6) containing 2 mM EDTA, 10% glycerol (v/v) and 1 mM DTT 
(buffer A) and applied onto Q-Sepharose Fast Flow column (120 ml, GE Healthcare). The column was washed 
with 0.5 l of buffer A and subsequently with 360 ml of buffer A containing 0.1 M KCl. The enzyme was eluted 
with a 1.24 l linear gradient of 0.1–0.3 M KCl in buffer A. Fractions were assessed for PNP activity (using the 
spectrophotometric assay) and for the purity (using the SDS-PAGE). The purest fractions were pooled (210 ml), 
concentrated in Amicon stirred cell (Millipore) to 24 ml volume and supplemented with an equal volume of 2 M 
ammonium sulfate. The enzyme was applied onto Phenyl-Sepharose CL-4B (30 ml, GE Healthcare) equilibrated 
with 50 mM HEPES pH 7.6 containing 1 M ammonium sulfate. The column was washed with 200 ml of the same 
buffer and subsequently with the same buffer containing 0.8 M and 0.6 M ammonium sulfate (200 ml each). 
The enzyme was eluted with decreasing step gradient of ammonium sulfate in 50 mM HEPES pH 7.6, from 0.5 
M to 0.1 M (100 ml each). The fractions containing PNP protein (named fraction 3 and fraction 4) were pooled 
separately, concentrated in the Amicon stirred cell, and dialysed against 10 mM HEPES pH 7.0 with two changes 
of dialysis buffer. The fraction 4, containing 60 mg of protein had slightly higher purity and therefore was used 
in all experiments described in this study. The protein was divided into small aliquots and stored frozen at − 80 
°C until further use.
The recombinant WT enzyme was purified in the same way as described in our earlier  publications13,18,19.
Enzyme activity and kinetic studies. All activity measurements and kinetic studies were done in 50 mM 
Hepes/HCl buffer pH 7.0 at 25 °C as previously described for the WT E. coli PNP and its active-site mutants, 
using direct spectrophotometric assay for adenosine, guanosine and 7-methylguanosine as substrates, and a 
coupled assay with xanthine oxidase in the case of  inosine13,28,29. Activity measurements were performed for each 
protein sample, before and after each experiment as a control of the state of the protein.
The classical Michaelis–Menten equation was fitted to the kinetic curves (i.e. initial rate of the reaction,  v0, 
vs. initial substrate concentration,  c0):
If the analysis of residual plots suggested that a more complex model was necessary to describe the data 
properly, a model taking into account allosteric interaction between active sites was applied:
where KM2 = aKM1 and Vmax2 = bVmax1 characterizes a free active site when one binding site is already occupied 
by the  ligands30. Coefficients a and b express the degree of cooperation between the subunits in a dimer, while 
constants KM1 and Vmax1 characterize the active sites of the enzyme when the neighbouring site is free.
A more complex model was used if there was a statistically significant decrease in the residual sum of squares 
as judged by the F test at 95% confidence level.
To determine inhibition model and inhibition constant for formycin A, rate of phosphorolysis with  m7Guo 
as a variable substrate, at constant, 50 mM, phosphate concentration, was registered in the absence of the inhibi-
tor and in the presence of two different concentrations of formycin. A global fitting to the whole data set was 
performed, using various models (competitive, uncompetitive, noncompetitive, mixed). As expected for the 
substrate analogue, competitive model described the data sufficiently well:
where  ci is inhibitor concentration. Kinetic data were analysed using the GraphPad Prism program (Intuitive 
Software for Science, San Diego, CA, USA).
Analytical ultracentrifugation. Sedimentation velocity experiments were conducted with an Optima 
XL-I (Beckman-Coulter Inc., Indianapolis, IN, USA) using the An-50Ti and An-60Ti analytical rotors, and 
double-sector 1.2-cm cells with Epon-charcoal centerpieces and sapphire windows. Partial specific volume of 
the Y160W mutant (from its amino acid composition), densities and viscosities of buffers were calculated using 
the Sednterp  program31. Protein sample in 50 mM Tris/HCl buffer pH 7.6 and 0.2 M NaCl was equilibrated at 20 
°C or at 4 °C, accelerated to 42,000 rpm (142,250 g) at the cell bottom and radial scans of the protein-absorption 
profile in the cell were measured at 5- or 7-min intervals. For the analysis, the continuous c(s) distribution model 
incorporated in the Sedfit  program32 was used. The sedimentation coefficient s and the standard sedimentation 
coefficient  s020,w were calculated, from which the molecular weight of the species present in the solution was 
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Crystallisation, data collection and structure solution. The Y160W protein was crystallised in the 
50 mM citrate buffer pH 5.2 and 14% ammonium sulfate (w/v) in the presence of 50 mM phosphate and/or 5 
mM formycin A, PNP concentration was 90 mg/ml. Crystals were obtained at 18 °C by the hanging-drop vapour 
diffusion method. Prior to flash-freezing in liquid nitrogen crystals were soaked in a cryoprotectant solution 
containing 30% glycerol. Data were collected at the beamline P14 operated by EMBL Hamburg at the PETRA 
III storage ring (DESY, Hamburg, Germany), images were processed with the  XDS33. The structure was solved 
by the molecular replacement with the Phaser, being a part of CCP4  suite34, and as a model PNP-WT (PDB 
 1ECP8) was used. The structure was refined with the Phenix.refine35 and  Coot36. The X-ray data collection and 
refinement statistics are shown in Table 4. The structure was deposited in the Protein Data Bank (PDB 6XZ2).
Fluorimetric titrations. All experiments were carried out on the Perkin-Elmer LS55 spectrofluorimeter. 
Fluorescence spectra were registered using in each case (protein or protein–ligand complex) several excitation 
wavelengths. Differential spectra were calculated by subtracting spectrum of a protein from the spectrum of the 
appropriate complex. The negative differential fluorescence intensity means that a decrease of fluorescence upon 
complex formation is observed. Titrations of the enzyme with phosphate were registered using several excitation 
and observation wavelengths combinations. When selecting  specific wavelengths for such a combination, two 
criteria were used: (1) the overall change in the fluorescence signal and (2) the complexity of the shape of the 
titration as the analysis of the multi-phasic curves is more explicit than a uni-phasic curve analysis.
Path length for the excitation was 2 mm and for the emission was 5 mm (half of the cuvette dimensions). A 
continuous stirring was used during titrations. All measurements were performed at 25 °C. Enzyme concen-
tration (as a monomer) was in the range of 0.5–2 μM. Molecular weight of the Y160W monomer used in all 
calculations was 25.970 kDa, and the molar extinction coefficient at absorption maximum ε278nm = 8 940  M−1 
 cm−1, corresponding to ε1%278 nm = 0.34537. Protein and ligand were dissolved in 50 mM Tris/HCl buffer pH 7.6, 
ligands stocks contained protein at the same concentration as in the reaction cuvette, as proposed by Breer et al.38, 
therefore, there was no protein dilution during titration and no correction  is needed.
Table 4.  X-ray data collection and refinement statistics. Statistics for the highest resolution shell are shown in 
parentheses.
Data collection
Space group P  61 2 2
Cell dimensions
a, b, c (Å) 120.47, 120.47, 239.80
α, β, γ (°) 90.00, 90.00, 120.00
Resolution (Å) 119.90–1.65 (1.68–1.65)
Total number of reflections 4,929,666 (189,722)
Total number unique 123,021 (5,869)
Rmerge 0.175 (1.483)
Rmeas 0.177 (1.507)
Mean I/σ(I) 14.7 (2.9)
Completeness (%) 99.8 (98.3)
Multiplicity 40.1 (32.3)
Refinement
Resolution (Å) 95.83–1.65 (1.68–1.65)
Total number of reflections 122,926
Rfree reflections 6,119
Rwork /Rfree 0.174/0.189 (0.220/0.270)





RMSD bonds (Å) 0.018
RMSD angles (°) 1.435
Ramachandran favored (%) 97.02
Ramachandran allowed (%) 2.84
Ramachandran outliers (%) 0.14
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Fluorescence intensity of the WT protein is stable over time, but in the case of the Y160W mutant a slight 
quenching of fluorescence is observed during titration, which typically lasted about 30 min as the time between 
each point in the titration was 1 min. Furthermore, adding phosphate during titration stabilises the intrinsic 
fluorescence of the protein. Therefore, for each phosphate concentration,  [Pi], used in titrations (each titration 
point), fluorescence intensity vs. time was measured, and for each of them the linear fit was found to be suffi-
cient to describe the data. Slopes of these lines, a([Pi]), plotted vs. phosphate concentration, give a typical decay 
curve, showing signal stabilisation upon increasing concentration of phosphate. Thus corrected binding curves, 
 Fcor([Pi]), are given by the following equation, in which  Fn([Pi]) is the fluorescence intensity measured for the 
phosphate concentration  [Pi], and n is the number of a given titration point in the particular titration:
At pH 7.6 phosphate is mostly in a form of a double-negative ion (pKa 7.2)39, thus ionic strength, I, of the 
solution raises significantly during titration with this ligand. To check its influence on the intrinsic protein 
fluorescence, titrations with NaCl were performed, giving dependence F(I). For the WT protein F(I) was found 
to be constant up to the ionic strength of about 100 mM, and then a steep decrease is observed. Titration curves 
of the WT protein with phosphate were therefore measured up to 100 mM ionic strength of solution, which is 
enough to observe a plateau. For the Y160W mutant a more complex dependence F(I) was observed, influenced 
also by the titration conditions (excitation and observation wavelengths). The dependence of the fluorescence on 
the ionic strength observed for the WT protein suggests that there is no specific influence of the increasing ionic 
strength on the protein intrinsic fluorescence. Therefore, to correct for the increase of the ionic strength caused 
by phosphate, the fluorescence intensity measured during titration with this ligand,  Fobs([Pi]) was divided by F(I), 
both obtained for the same ionic strength, to get fluorescence intensity curve,  Fbind([Pi]) in which changes of the 
fluorescence observed are caused only by the phosphate biding to the enzyme. Both  Fobs([Pi]) and F(I) were cor-
rected for the time dependent fluorescence quenching, according to Eq. (4), prior to the  Fbind([Pi]) calculation.
Titrations were performed in series (consisting of five to eight curves), and analysed globally using the 
DynaFit4  program40 (see below).
Calorimetric titrations. The isothermal titration experiments were performed on the MicroCal iTC200 
(Malvern) microcalorimeter. Before each experiment, protein solution was dialysed against 50 mM Tris/HCl 
buffer pH 7.6, and ligands were dissolved in a dialysate buffer, subsequently all samples were filtered using 0.22 
μm pore diameter filters, and degassed. All experiments were carried out at 25°C. For the WT protein series of 
three calorimetric titrations, with protein concentration in the range of 70 to 800 μM, for the Y160W mutant 
series of four titration with protein concentration in the range of 300 μM to 1.3 mM were performed. Samples 
of each protein used for these series came from a single preparation. Ligand samples were 8–12 times more con-
centrated than the protein sample, in order to achieve a diverse ligand/protein molar ratio during titration and 
thus better explore binding  curves41. In some ITC experiments, in order to sample the lower plateau region more 
accurately, several initial points were measured with less ligand volume added at each step than used in the sub-
sequent titration points measurements. An example of the ITC data is shown in the Supplementary Information 
(Figure S6). Raw thermograms were analysed with  NITPIC43. Global analysis of titration curves was performed 
with  Sedphat20,21.
MST experiments. Measurements were performed with Monolith NT115 (NanoTemper). Enzyme was 
labelled with NT647 fluorescent dye (NanoTemper) according to the protocol provided by the manufacturer. 
Labelled proteins show fluorescence excitation and emission maxima of approximately 650 and 670 nm, respec-
tively. The series of titrations were performed at a constant protein concentration. Both proteins (WT and 
mutant), and ligands were dissolved in 50 mM Tris/HCl pH 7.6 buffer, measurements were performed at 25 
°C. We have proved previously, that PNP-WT is stable over a broad range of  temperatures13, thus temperature 
rise in the focal volume during MST experiment, typically 2–6 °C42 should have no significant influence on the 
protein activity and its biding capability. In the pre-experiments, it was carefully checked for both proteins, WT 
and Y160W mutant whether any sign of aggregation or inactivation occurs, and if mutant behaviour is similar 
to that of the WT enzyme. An example of the raw thermophoretic curves obtained with the relative heating laser 
power at 60% and 80% are shown in the Supplementary Information (Figure S7).
For experiments of the binary complex formation with phosphate, curves were measured at four different 
powers of the heating laser. Two to five titrations at each heating power were measured, and curves were averaged 
for a particular heating power. Global fitting was performed for a series of all four titration curves obtained at 
four heating laser powers. Protein concentrations in capillaries were 0.14 μM for the WT and 0.21 μM for the 
Y160W mutant. Ligand concentration was in the range of 3.5 nM—750 mM. The standard sixteen point curves 
were insufficient to test necessary ligand concentration range, thus measurements for two ligand concentration 
ranges were performed. Concentrations were selected so that three to four points from each range overlap, 
allowing to stitch obtained curves into one titration curve, covering entire required ligand concentration range. 
Measurements have been made for high concentrations of phosphate in order to investigate if for the concentra-
tion above about 50 mM, any additional binding constants can be observed. This is an area inaccessible in fluo-
rescence titration due to the quenching of the protein fluorescence at such a high ionic strength of the solution. 
It was verified that so high ionic strength does not affect the fluorescence of the dye used to label the protein.
Experiments of the nucleoside analogue binding were performed in the presence of saturating concentration 
of phosphate, i.e. 50 mM. For both, WT PNP and Y160W mutant seven repetitions of each curve were meas-
ured, for a single power of the heating laser. The power of the heating laser at which the strongest change of the 
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thermophoretic signal upon ligand binding occurs was selected, namely 80% for both enzyme variants. The raw 
MST traces, for two highest tested laser powers, 60% and 80%, are presented in the Supplementary information 
(Figure S7) Protein concentration in the capillary was constant and equal to 0.215 μM and 0.0751 μM for the 
WT protein and the Y160W mutant, respectively. Series of titrations were analysed globally using the DynaFit4 
 program40 (see below).
CD titrations. Experiments were performed with Chirascan spectrophotometer (Applied Photophysics), in 
the near UV region (240–290 nm), thus in the region where aromatic amino acids absorb. Full spectra of the pro-
tein/complex were recorded, with 0.2 nm resolution and 2 s averaging per point. Enzyme concentration was in 
the range of 20–120 μM, the 50 mM Tris/HCl buffer pH 7.6 was used, ligands were dissolved in the same buffer. 
All measurements were performed at 25 °C. Upon addition of each volume of phosphate solution spectrum was 
recorded in the range 230–300 nm, in the amino acids absorption region, with 0.25 nm step and 2 s per point 
signal averaging. Spectra were smoothed with Savitzky-Golay  algorithm44 using a fourth degree polynomial 
and eleven points in the averaging window. The wavelengths of the greatest signal change were determined by 
calculating differential spectra. These wavelengths were used to plot the titration curves. Global analysis of five 
to seven curves was performed with  DynaFit440.
Global analysis of binding curves. Three models were taken into account in analysis of binding curves: 
model with one (first equation below), two (first two equations) and three binding sites.
The model with one binding site is based on the assumption that all monomers are equivalent, and there is 
no cooperation between them. In the model with two binding sites the basic functional unit of the protein is 
a dimer, possible non-equivalence of binding sites or cooperativity between active sites in the dimer are taken 
into account (in the case of no cooperativity dissociation constants should be related statistically:  Kd2 =  4Kd1), 
the dimers within hexamer are equivalent. The model with three binding sites is based on the crystallographic 
structures of binary and ternary complexes of PNP with ligands, where two of the dimers are in the “open-closed” 
conformation, but the third dimer is symmetrical, in the “open-open” conformation. Thus, active sites in the 
open conformation belonging to “open-closed” and “open-open” dimer may not be equivalent. This model takes 
into account possibility of cooperation between all monomers within a hexameric molecule of the protein (in the 
case of no cooperativity dissociation constants should be related statistically:  Kd3 =  9Kd1,  Kd2 =  3Kd1).
Titration series were analysed globally, always starting from the simplest, one-binding-site model. If the 
residual plots, judged visually and by Runs of Sign Test/Wald-Wolfowitz Runs Test (WWtest)22, suggested that 
one-binding-site model does not describe data well, the two-binding-site model was tested. Only if the analysis 
of the residual plots for the two-binding-site model, judged by the WWtest, suggested that still more complex 
model should be tested, the three-binding-site model was fitted, and the residual plots analysis was performed for 
the results. For all tested models the Akaike information  criterion23 was also calculated. Generally both criteria 
used in the discrimination analysis were pointing the same model as best describing the data. The only exception 
was thermophoretic titration of the WT protein with formycin A, and it is described in details in the Results. 
Analysed models were fitted to the raw data, whereas graphs presented in this study were prepared from the 
normalised data and the fitted curves. The parameters of the fit are dissociation constants and responses of the 
system. Responses are defined as changes in a measured physical quantity related to the formation of subsequent 
protein–ligand complexes: intrinsic protein fluorescence intensity, fluorescence intensity of the dye, heat and 
ellipticity for fluorimetric, thermophoretic, calorimetric and CD titrations, respectively. Responses are normalised 
for the protein concentration present in the titration, thus giving molar coefficients.
Many titration curves obtained in this study are uniphasic. In the Supplementary Information (Figure S8) 
an example of such a uniphasic titration curve is shown (WT PNP titration with Pi, followed by the near-UV 
CD detection), with one-, two- and three-binding site models fitted. Respective residual plots are also included. 
Although the signal changes monotonically it is clear even on the basis of the visual inspection that the one-
binding site model should be rejected. In turn, the residual plots indicate that the two-binding site model should 
be rejected as well.
Accession number. Structural data are available in PDB database under accession number PDB 6XZ2.
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